BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19593570)

  • 1. Macrophage activation syndrome in malaria.
    Dass R; Barman H; Duwarah SG; Choudhury V; Jain P; Deka NM; Murari M
    Rheumatol Int; 2010 Jun; 30(8):1099-101. PubMed ID: 19593570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin.
    Sztajnbok F; Fonseca AR; Campos LR; Lino K; Rodrigues MCF; Silva RM; de Almeida RG; Perazzio SF; Carvalho MFF
    Adv Rheumatol; 2024 Apr; 64(1):28. PubMed ID: 38627860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome in a child affected by malaria: the choice of steroid.
    Trapani S; Canessa C; Fedi A; Giusti G; Barni S; Montagnani C; Galli L; Resti M; De Martino M
    Int J Immunopathol Pharmacol; 2013; 26(2):535-9. PubMed ID: 23755771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
    Minoia F; Bovis F; Davì S; Insalaco A; Lehmberg K; Shenoi S; Weitzman S; Espada G; Gao YJ; Anton J; Kitoh T; Kasapcopur O; Sanner H; Merino R; Astigarraga I; Alessio M; Jeng M; Chasnyk V; Nichols KE; Huasong Z; Li C; Micalizzi C; Ruperto N; Martini A; Cron RQ; Ravelli A; Horne A;
    J Pediatr; 2017 Oct; 189():72-78.e3. PubMed ID: 28807357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in pediatrics.
    Alongi A; Naddei R; De Miglio L; Natoli V; Ravelli A
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():13-15. PubMed ID: 32017214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Shimizu M
    Immunol Med; 2021 Dec; 44(4):237-245. PubMed ID: 33982649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Activation Syndrome in Scleroderma.
    Hone N; Donnelly C; Houk JB; Mina R
    J Clin Rheumatol; 2017 Mar; 23(2):120-121. PubMed ID: 28225516
    [No Abstract]   [Full Text] [Related]  

  • 8. Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report.
    Peterlin P; Garnier A; Le Bourgeois A; Jullien M; Seguin A; Eveillard M; Béné MC; Guillaume T; Chevallier P
    Acta Haematol; 2022; 145(5):537-541. PubMed ID: 35724631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma.
    Pascarella A; Bracaglia C; Caiello I; Arduini A; Moneta GM; Rossi MN; Matteo V; Pardeo M; De Benedetti F; Prencipe G
    Front Immunol; 2021; 12():663329. PubMed ID: 33815425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
    Karakike E; Giamarellos-Bourboulis EJ
    Front Immunol; 2019; 10():55. PubMed ID: 30766533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
    Krei JM; Møller HJ; Larsen JB
    Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
    Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
    Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
    J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome in autoimmune disease.
    Deane S; Selmi C; Teuber SS; Gershwin ME
    Int Arch Allergy Immunol; 2010; 153(2):109-20. PubMed ID: 20407267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
    Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
    Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective.
    Nguyen TTT; Kim YT; Jeong G; Jin M
    Exp Mol Med; 2024 Mar; 56(3):559-569. PubMed ID: 38448692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
    Moling O; Piccin A; Tauber M; Marinello P; Canova M; Casini M; Negri G; Raffeiner B; Binazzi R; Gandini L; Vecchiato C; Rimenti G; Billio A
    J Med Case Rep; 2016 Sep; 10(1):254. PubMed ID: 27634631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macrophage activation syndrome complicating family lymphohistiocytosis].
    Boussaadni YE; Benajiba N; Bousfiha AA; Ailal F
    Pan Afr Med J; 2017; 26():93. PubMed ID: 28491224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.